Showing 2,601 - 2,620 results of 123,450 for search '(( 2 d decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 2.25s Refine Results
  1. 2601
  2. 2602
  3. 2603
  4. 2604
  5. 2605
  6. 2606
  7. 2607
  8. 2608
  9. 2609

    Decreased expression of genes related to cholesterol biosynthesis and lipogenesis in PCA. by Sreejith P. Panicker (159572)

    Published 2012
    “…The results of the analysis for LPP are shown in 1A, for CCCA in 1B, for FFA in 1C and for TF in 1D. …”
  10. 2610

    Loperamide decreases mechanical responsiveness of unmyelinated, nociceptive C-fibers. by Matthias Ringkamp (253465)

    Published 2013
    “…Dashed line indicates threshold assigned to afferents unresponsive to 25 g vF hair. B) Loperamide dose-dependently decreases the responsiveness to suprathreshold mechanical stimuli in both animal groups (ANOVA lesion: F<sub>(3,35)</sub> = 10.3, p<0.001; ANOVA sham: F<sub>(3,16)</sub> = 4.5, p<0.05). …”
  11. 2611
  12. 2612
  13. 2613
  14. 2614
  15. 2615

    PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues. by Hiromi Hyodo (484509)

    Published 2013
    “…One unit means a decrease in OD<sub>620</sub> per second. …”
  16. 2616
  17. 2617
  18. 2618

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  19. 2619

    Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  20. 2620